Integrin Activation Contributes to Lower Cisplatin Sensitivity in MV3 Melanoma Cells by Inducing the Wnt Signalling Pathway.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 125, doi. 10.3390/cancers9090125
- Publication type:
- Article
Works matching IS 20726694 AND DT 2017 AND VI 9 AND IP 9
Results: 18
1
2
Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 127, doi. 10.3390/cancers9090127
- By:
- Publication type:
- Article
3
The Impact of DNA Repair Pathways in Cancer Biology and Therapy.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 126, doi. 10.3390/cancers9090126
- By:
- Publication type:
- Article
4
MicroRNAs as Biomarkers in Colorectal Cancer.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 124, doi. 10.3390/cancers9090124
- By:
- Publication type:
- Article
5
Anaplastic Lymphoma Kinase in Cutaneous Malignancies.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 123, doi. 10.3390/cancers9090123
- By:
- Publication type:
- Article
6
Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 111, doi. 10.3390/cancers9090111
- By:
- Publication type:
- Article
7
Integrins as Therapeutic Targets: Successes and Cancers.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 110, doi. 10.3390/cancers9090110
- By:
- Publication type:
- Article
8
EMT and Treatment Resistance in Pancreatic Cancer.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 122, doi. 10.3390/cancers9090122
- By:
- Publication type:
- Article
9
The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 121, doi. 10.3390/cancers9090121
- By:
- Publication type:
- Article
10
Acute and Late Toxicities of Concurrent Chemoradiotherapy for Locally-Advanced Non-Small Cell Lung Cancer.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 120, doi. 10.3390/cancers9090120
- By:
- Publication type:
- Article
11
Reduced Cytokine Release in Ex Vivo Response to Cilengitide and Cetuximab Is a Marker for Improved Survival of Head and Neck Cancer Patients.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 117, doi. 10.3390/cancers9090117
- By:
- Publication type:
- Article
12
Predicting Organ-Specific Risk Interactions between Radiation and Chemotherapy in Secondary Cancer Survivors.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 119, doi. 10.3390/cancers9090119
- By:
- Publication type:
- Article
13
EML4-ALK Variants: Biological and Molecular Properties, and the Implications for Patients.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 118, doi. 10.3390/cancers9090118
- By:
- Publication type:
- Article
14
Most Do, but Some Do Not: CD4<sup>+</sup>CD25<sup>- </sup>T Cells, but Not CD4<sup>+</sup>CD25<sup>+</sup> Treg Cells, Are Cytolytic When Redirected by a Chimeric Antigen Receptor (CAR).
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 112, doi. 10.3390/cancers9090112
- By:
- Publication type:
- Article
15
Exploring the Role of RGD-Recognizing Integrins in Cancer.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 116, doi. 10.3390/cancers9090116
- By:
- Publication type:
- Article
16
Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM).
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 115, doi. 10.3390/cancers9090115
- By:
- Publication type:
- Article
17
Stem Cell-Like Properties of CK2p-down Regulated Mammary Cells.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 114, doi. 10.3390/cancers9090114
- By:
- Publication type:
- Article
18
Novel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck.
- Published in:
- Cancers, 2017, v. 9, n. 9, p. 113, doi. 10.3390/cancers9090113
- By:
- Publication type:
- Article